Skip to main content

AI Advancements Could Be Boon for Biotech Industry

Generative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started. One exciting element about AI from an investment perspective is that upcoming advancements could spell opportunity. Part of that conversation should include AI interacts and intersects with other disruptive, innovative industries. Healthcare is included in that group, [...] The post AI Advancements Could Be Boon for Biotech Industry appeared first on ETF Trends .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.